GE HealthCare Technologies (GEHC) vs MBody AI (MBAI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GE HealthCare Technologies (GEHC) has outperformed MBody AI (MBAI) over the past year, losing 14.5% versus a loss of 79.9%. GE HealthCare Technologies is the larger company by market cap ($29.69 billion vs $49.8 million), about 596.5 times the size. On valuation, MBody AI trades at a lower trailing P/E (0.7x vs 15.1x for GE HealthCare Technologies).
GE HealthCare Technologies pays a dividend yielding 0.21%, while MBody AI does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GEHC | MBAI |
|---|---|---|
| Share price | $65.74 | $3.26 |
| Market cap | $29.69B | $49.78M |
| 1-day change | +2.37% | +8.14% |
| YTD return | -21.70% | -73.46% |
| 1-year return | -14.52% | -79.91% |
| 5-year return | — | -97.43% |
| P/E ratio (TTM) | 15.11 | 0.70 |
| Forward P/E | 12.15 | — |
| EPS (TTM) | $4.35 | $4.65 |
| Dividend yield | 0.21% | 0.00% |
| Annual dividend | $0.14 | $0.00 |
| Revenue (latest FY) | $20.63B | — |
| Revenue growth (YoY) | +4.84% | — |
| Net income (latest FY) | $2.08B | — |
| Gross margin | 39.99% | — |
| Operating margin | 13.40% | — |
| Net margin | 10.10% | — |
| 52-week high | $89.77 | $27.44 |
| 52-week low | $58.75 | $3.00 |
| Distance from 52-week high | -26.77% | -88.14% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +26.10% | +207.22% |
| Average volume | 4.11M | 20.96K |
| Shares outstanding | 451.69M | 15.29M |
| Employees | 54,000 | — |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GE HealthCare Technologies is about 596.5 times larger than MBody AI by market value ($29.69B vs $49.78M).
- GEHC has outperformed MBAI by 65.4 percentage points over the past year.
- GE HealthCare Technologies trades at a higher earnings multiple (15.1x vs 0.7x trailing P/E).
About GE HealthCare Technologies
GEHC stock →GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
Health Care · Medical Electronics · 54,000 employees
About MBody AI
MBAI stock →MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation.
Health Care · Medical Electronics
GEHC vs MBAI FAQ
Which is bigger, GE HealthCare Technologies or MBody AI?
GE HealthCare Technologies (GEHC) is larger, with a market capitalization of $29.69B compared with $49.78M for MBody AI (MBAI).
Which stock has performed better over the past year, GEHC or MBAI?
GEHC returned -14.52% over the past 12 months, compared with -79.91% for MBAI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GEHC or MBAI?
MBAI has the lower trailing P/E at 0.7, versus 15.1 for GEHC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, GE HealthCare Technologies or MBody AI?
GE HealthCare Technologies pays a dividend yielding 0.21%, while MBody AI does not currently pay a regular dividend.
Are GE HealthCare Technologies and MBody AI in the same industry?
Yes. Both are classified in the Medical Electronics industry within the Health Care sector.